Lipum

Lipum Overview

Founded 2010
Founded
Status Private
Latest Deal Type Grant
Latest Deal Amount $2.69M
Latest Deal Amount
Investors 5

Lipum General Information

Description

Developer of biological anti-inflammatory drugs intended to eliminate or alleviate painful symptoms of patients suffering from chronic inflammatory diseases. The company's drugs address the treatment of Juvenile Iodiopathic Artrithis (JIA) that is a rare disease affecting children, enabling doctors to treat rheumatoid arthritis in children.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Tvistevägen 48C
  • 907 36 Umeå
  • Sweden
+46 090-340 00 00

Lipum Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lipum Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 05-Mar-2019 $2.69M 00.000 Completed Product Development
5. Later Stage VC 05-Mar-2019 00.000 00.000 Completed Product Development
4. Grant 01-Dec-2016 000.00 00000 Completed Product Development
3. Early Stage VC 24-Aug-2016 00000 00000 Completed Product Development
2. Seed Round 01-Jan-2011 Completed Product Development
1. Accelerator/Incubator Completed Product Development

Lipum Executive Team (5)

Name Title Board Seat Contact Info
Einar Pontén Ph.D Chief Executive Officer
Susanne Lindquist Ph.D Chief Scientific Officer & Co-Founder
Pernilla Abramsson Ph.D Chief Operating Officer
Olle Hernell Ph.D Co-Founder & Board Member

1 Former Executive

Lipum Board Members (3)

Name Representing Role Since
Lennart Lundberg Ph.D Self Board Member & Co-Founder 000 0000
Olle Hernell Ph.D Lipum Co-Founder & Board Member 000 0000
Ulf Björklund Lipum Chairman of the Board 000 0000

Lipum Investors (5)

To view Lipum‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
Almi Invest Venture Capital Minority 000 0000 000000 0
Innovationsbron Venture Capital Minority 000 0000 000000 0
Novo Holdings Corporate Venture Capital Minority 000 0000 000000 0
Umeå Biotech Incubator Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial